Welcome to the 2021 IGCS Meeting Program Scheduling
The meeting will officially run on Central European Time (Rome time-zone, GMT+2)
To convert the meeting times to your local time Click Here
Hall 2
Session Type
Surgical Films
Room
Hall 2
Date
08/30/2021
Session Type
Surgical Films
Room
Hall 2
Date
08/31/2021
Session Type
Surgical Films
Room
Hall 2
Date
09/02/2021
Session Type
Postgraduate Education
Room
Hall 2
Date
09/02/2021
Session Description
Session Description:This course will discuss the sexual function care of post treatment patients after gynecologic cancer, focusing on cisgender patients. Sexuality and gender minority patients experience disparities in screening, the role of systems and providers will be discussed. Providers caring for transgender gyn cancer patients have few guidelines. The development of evidence based practices directed towards these patients will be discussed.
Hall 1
Session Type
Plenary Session
Room
Hall 1
Date
08/30/2021
Session Type
Tumor Board
Room
Hall 1
Date
08/30/2021
Chair(s)
Session Description
Session Description: Three cases will be discussed amongst a multidisciplinary panel including a radiation oncologist, pathologist, and several gynecologic oncologists. Live audience polling will allow delegates to participate in real-time.
Session Type
Master Session
Room
Hall 1
Date
08/30/2021
Chair(s)
Session Description
Session Description: This interactive and exciting session will feature international thought leaders in cervical cancer to discuss challenges in the current standard of care, from prevention to second-line and greater chemotherapy. The first half of the session will discuss the current status of HPV vaccination, the gap between cervical cancer incidence and eradication, and clinical dilemmas in stage allocation and surgery/radiation overlap for optimal patient management in low volume disease. The second half will discuss ongoing and resulted clinical trial that are ushering in a new era of immunotherapy for locally advanced and metastatic/recurrent cervical cancer.
This session is supported by Industry.